Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 78 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Keyword is Helicobacter pylori [Clear All Filters]
Controlling the Impact of -Related Hyperhomocysteinemia on Neurodegeneration..
Medicina (Kaunas). 59(3),
(2023). Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities..
Aliment Pharmacol Ther. 57(10), 1186-1187.
(2023). Emerging parameters relevant to the management of antimicrobial-resistant Helicobacter pylori infection..
Intern Med J. 52(9), 1654-1655.
(2022). GM-CSF as a potential candidate of a vaccine-induced reduction of Helicobacter pylori infection..
Helicobacter. 27(3), e12884.
(2022). Impact of Active Helicobacter pylori Infection-related Metabolic Syndrome on Systemic Arterial Hypertension..
Arq Bras Cardiol. 119(3), 502-504.
(2022). Letter to the Editor Regarding "The Association of Helicobacter pylori, Eradication, and Early Complications of Laparoscopic Sleeve Gastrectomy" by Abeid et al..
Obes Surg. 32(6), 2079-2080.
(2022). A potential impact of Helicobacter pylori-related metabolic syndrome on early and long-term outcomes of bariatric surgery..
Gastrointest Endosc. 96(6), 1088-1089.
(2022). Letter: Helicobacter pylori infection and its role in oesophageal adenocarcinoma..
Aliment Pharmacol Ther. 51(11), 1215-1216.
(2020).
(2020). Helicobacter pylori infection and gastric cancer biology: tempering a double-edged sword..
Cell Mol Life Sci. 76(13), 2477-2486.
(2019). Microbes and Alzheimer' disease: lessons from H. pylori and GUT microbiota..
Eur Rev Med Pharmacol Sci. 23(5), 1845-1846.
(2019). Helicobacter pylori Infection and Gastroesophageal Reflux Disease-Barrett's Esophagus-Esophageal Adenocarcinoma Sequence..
Am J Gastroenterol. 113(11), 1723-1724.
(2018). Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology..
Dig Dis Sci. 63(4), 1087-1088.
(2018).
(2018). Active Infection Is a Risk Factor for Colorectal Mucosa: Early and Advanced Colonic Neoplasm Sequence..
Gut Liver. 11(5), 733-734.
(2017). Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy..
Int J Cardiol. 229, 17-18.
(2017). Comment on "Effect of biofilm formation by clinical isolates of Helicobacter pylori on the efflux-mediated resistance to commonly used antibiotics"..
World J Gastroenterol. 23(33), 6194-6196.
(2017). Helicobacter pylori eradication to prevent cardio-cerebrovascular disease: Are current data useful for clinical practice?.
Int J Cardiol. 233, 92.
(2017). Helicobacter pylori on portal hypertension-related hepatic encephalopathy..
Immunopharmacol Immunotoxicol. 39(2), 105-106.
(2017). Helicobacter pylori-related chronic hepatitis C infection and the risk for cardiovascular disease..
Liver Int. 37(7), 1082.
(2017). Helicobacter pylori-related metabolic syndrome as predictor of progression to esophageal carcinoma in a subpopulation-based Barrett's esophagus cohort..
Gastrointest Endosc. 85(2), 462-463.
(2017). Impact of reactive oxygen species generation on Helicobacter pylori-related extragastric diseases: a hypothesis..
Free Radic Res. 51(1), 73-79.
(2017). Letter: Helicobacter pylori in lean and obese patients with non-alcoholic fatty liver disease..
Aliment Pharmacol Ther. 46(6), 637-638.
(2017). Letter: Helicobacter pylori-related non-alcoholic fatty liver disease with concomitant metabolic syndrome as risk factor for colorectal neoplasia..
Aliment Pharmacol Ther. 45(4), 576-577.
(2017). Novel aspects of defensins' involvement in virus-induced autoimmunity in the central nervous system..
Med Hypotheses. 102, 33-36.
(2017). Σελίδες
- 1
- 2
- 3
- 4
- επόμενη ›
- τελευταία »